Registered entities
AVENCELL THERAPEUTICS, INC
Reg. No. 87-1778098United States
Avencell Europe Gmbh
Reg. No. U1104_HRB30429Germany
Social engagement
Social engagement: 4.3K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Novo Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 30% |
| Private equity | 1 | 10% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 5 | 50% |
Recent activity
2 Jun 2026
Event
EHA 2026
4 Dec 2025
Milestone
regulatory